Health Insurance Zug

Health Insurance Zug

ProLiant (R) (Denosumab) approved for marketing in the European Union Thousand Oaks, Calif., May 28, 2010 (ots / PRNewswire) – Amgen announced today that the European Commission (EC) has granted permission for ProLiant (R) (denosumab) for the treatment of osteoporosis postmenopausal women to …

Comments

Tell me what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

You must be logged in to post a comment.


Warning: file_get_contents() [function.file-get-contents]: Filename cannot be empty in /home/wiseeagl/public_html/health-insurance-policy.net/wp-content/plugins/rss-randomizer/forge.php on line 60